Brain Metastases News and Research

RSS
AACR to honor UNC scientist with $181,000 grant for breast cancer research

AACR to honor UNC scientist with $181,000 grant for breast cancer research

BMY receives FDA approval for YERVOY to treat metastatic melanoma

BMY receives FDA approval for YERVOY to treat metastatic melanoma

Researchers verify several factors associated with increased risk of brain metastases in breast cancer patients

Researchers verify several factors associated with increased risk of brain metastases in breast cancer patients

Noncancerous cells from primary site appear to facilitate tumor growth: Study

Noncancerous cells from primary site appear to facilitate tumor growth: Study

Anti-cancer drug smuggled using a nanocarrier past protective blood-brain barrier into brain tumours

Anti-cancer drug smuggled using a nanocarrier past protective blood-brain barrier into brain tumours

Effective treatment for brain cancer in daffodils

Effective treatment for brain cancer in daffodils

Frameless radiosurgery can treat most sensitive regions of brain: Study

Frameless radiosurgery can treat most sensitive regions of brain: Study

Angiochem presents positive Phase 1/2 clinical data of ANG1005 for brain cancer at ASCO 2010

Angiochem presents positive Phase 1/2 clinical data of ANG1005 for brain cancer at ASCO 2010

YM BioSciences initiates enrollment in nimotuzumab trial in brain metastases from NSCLC

YM BioSciences initiates enrollment in nimotuzumab trial in brain metastases from NSCLC

Study: PDE5 inhibitors may increase permeability of blood brain barrier to Herceptin

Study: PDE5 inhibitors may increase permeability of blood brain barrier to Herceptin

Elekta Neuromag tool to be highlighted at AANS 2010 Annual Meeting

Elekta Neuromag tool to be highlighted at AANS 2010 Annual Meeting

Preclinical data of ANG1005 and ANG1007 for treatment of brain cancer presented at AACR 2010

Preclinical data of ANG1005 and ANG1007 for treatment of brain cancer presented at AACR 2010

YM BioSciences' nimotuzumab Phase II trials: FDA advises patient enrollment

YM BioSciences' nimotuzumab Phase II trials: FDA advises patient enrollment

UPMC reports 10,000th patient treated using Elekta's Leksell Gamma Knife system

UPMC reports 10,000th patient treated using Elekta's Leksell Gamma Knife system

Researchers follow steps that lead some tumor cells to establish metastases

Researchers follow steps that lead some tumor cells to establish metastases

UVA acquires Extend to broaden the potential for Gamma Knife Perfexion

UVA acquires Extend to broaden the potential for Gamma Knife Perfexion

Varian Medical Systems introduces RapidArc radiotherapy technology in Finland

Varian Medical Systems introduces RapidArc radiotherapy technology in Finland

Texas researchers identify new detection method for circulating tumor cells

Texas researchers identify new detection method for circulating tumor cells

New brain metastases treatment guidelines

New brain metastases treatment guidelines

TGen scientists win $1,000 prize for best scientific paper presented at BIBM09

TGen scientists win $1,000 prize for best scientific paper presented at BIBM09